Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03697564
Brief Title: Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer Achieving Disease Control in Response to First-line Chemotherapy (GemCaN Trial).

First Submitted : September 28, 2018
First Submitted that Met QC Criteria : October 3, 2018
First Posted : October 5, 2018

Last Update Submitted that Met QC Criteria : May 2, 2019
Last Update Posted : May 6, 2019